Kennedy Laura, Vass J Keith, Haggart D Ross, Moore Steve, Burczynski Michael E, Crowther Dan, Miele Gino
Translational Medicine Research Collaboration Laboratory, Sir James Black Centre, University of Dundee, Dundee, DD1 5EH, U.K.
Biomark Insights. 2008 Aug 25;3:403-417. doi: 10.4137/bmi.s938.
Peripheral blood as a surrogate tissue for transcriptome profiling holds great promise for the discovery of diagnostic and prognostic disease biomarkers, particularly when target tissues of disease are not readily available. To maximize the reliability of gene expression data generated from clinical blood samples, both the sample collection and the microarray probe generation methods should be optimized to provide stabilized, reproducible and representative gene expression profiles faithfully representing the transcriptional profiles of the constituent blood cell types present in the circulation. Given the increasing innovation in this field in recent years, we investigated a combination of methodological advances in both RNA stabilisation and microarray probe generation with the goal of achieving robust, reliable and representative transcriptional profiles from whole blood. To assess the whole blood profiles, the transcriptomes of purified blood cell types were measured and compared with the global transcriptomes measured in whole blood. The results demonstrate that a combination of PAXgene() RNA stabilising technology and single-stranded cDNA probe generation afforded by the NuGEN Ovation RNA amplification system V2() enables an approach that yields faithful representation of specific hematopoietic cell lineage transcriptomes in whole blood without the necessity for prior sample fractionation, cell enrichment or globin reduction. Storage stability assessments of the PAXgene() blood samples also advocate a short, fixed room temperature storage time for all PAXgene() blood samples collected for the purposes of global transcriptional profiling in clinical studies.
外周血作为转录组分析的替代组织,在发现疾病诊断和预后生物标志物方面具有巨大潜力,尤其是当疾病的靶组织难以获取时。为了最大限度地提高从临床血液样本生成的基因表达数据的可靠性,样本采集和微阵列探针生成方法都应进行优化,以提供稳定、可重复且具有代表性的基因表达谱,如实反映循环中存在的组成血细胞类型的转录谱。鉴于近年来该领域创新不断,我们研究了RNA稳定化和微阵列探针生成方面的一系列方法进展,目标是从全血中获得稳健、可靠且具有代表性的转录谱。为了评估全血谱,我们测量了纯化血细胞类型的转录组,并将其与全血中测量的整体转录组进行比较。结果表明,PAXgene()RNA稳定技术与NuGEN Ovation RNA扩增系统V2()提供的单链cDNA探针生成相结合,能够实现一种方法,无需事先进行样本分级、细胞富集或珠蛋白减少,就能在全血中如实呈现特定造血细胞谱系的转录组。对PAXgene()血样的储存稳定性评估还表明,对于临床研究中为进行整体转录谱分析而采集的所有PAXgene()血样,应在室温下进行短时间固定储存。